Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Earnings callYahoo Finance· January 27, 2026

Community Bank (CBU) Earnings Call Transcript

View original at finance.yahoo.com
Community Bank (CBU) Earnings Call Transcript Image source: The Motley Fool. Date Tuesday, Jan. 27, 2026 at 11 a.m. ET Call participants President and Chief Executive Officer — Dimitar Karaivanov Chief Financial Officer — Mariah Loss Need a quote from a Motley Fool analyst?…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Automation initiatives have saved 200,000+ hours over 3 years while keeping headcount flat as business grew

    80% confidence
  • Provision for credit losses in 2026 is expected to be $20M-$25M

    80% confidence
  • The company plans to continue making 8-12 acquisitions annually, mostly in fee businesses, characterized as small 'singles/doubles'

    80% confidence
  • Insurance Services growth is expected to be mid-single digits in 2026

    80% confidence
  • Wealth Management Services growth is expected to be mid-single digits in 2026

    80% confidence
  • Management wants to own more of the company, not less, indicating confidence in prospects

    80% confidence
  • Employee Benefit Services growth is expected to be mid-to-high single digits in 2026

    80% confidence
  • Community Bank achieved 16% operating earnings growth in 2025 while making the largest organic growth investments that the company has ever made

    80% confidence
  • Noninterest revenue growth for 2026 is expected to be 4%-8%

    80% confidence
  • Net interest income growth for 2026 is expected to be 8%-12%

    80% confidence
  • De novo deposits target for 2026 is approximately $200M, double from $100M in 2025, with path to $1B+ over 7-10 years

    80% confidence
  • Q1 2026 NIM expansion is expected to be 2-4 basis points

    80% confidence
  • Loan growth for 2026 is expected to be 3.5%-6%

    80% confidence
  • Effective tax rate for 2026 is expected to be 23%-24%

    80% confidence
  • Core noninterest expenses for 2026 are expected to be $535M-$550M, representing 4%-7% growth versus 2025

    80% confidence
  • Loan origination yields in Q4 were in the low 6% range and trending lower, potentially reaching below 6% by end of Q1/Q2 2026

    80% confidence
  • Deposit growth for 2026 is expected to be 2%-3%

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com